Research roundup: September edition 
We’ve searched the journals and read the practice updates to round up this month’s top research and guidelines on birth control, sexual health, abortion, STIs, and more!
read the full article »U=U (Undetectable = Untransmittable)Talking to your patients with HIV about their transmission risk
People living with HIV often have questions about the risk of passing HIV to their negative partners. Recent research has shown HIV treatment with antiretriviral therapy (ART) antiretroviral therapy (ART) to maintain consistently undetectable levels of HIV are effectively unable to transmit HIV to their sexual partners, commonly referred to as U=U or “Undetectable = Untransmittable.
read the full article »What makes the Liletta IUD different from Mirena?Here’s what you and your patients should know about these two (very similar) hormonal IUDs.
Many of you are likely already stocking and placing Liletta, the levonorgestrel intrauterine system (IUS, a.k.a. IUD) introduced in 2015. But you and your patients may still be trying to sort out how Liletta is different from—or very similar to—another IUD that’s been out there for years, the Mirena. Here are the details.
read the full article »Exciting News – LILETTA now approved for use up to 5 years! The FDA has extended approval of LILETTA IUDs for up to 5 years of use, research shows they are safe and effective for up to 7 years.
read the full article »Is LARC a silver bullet to end unplanned pregnancy?Experts weigh in on how many women would use IUDs and implants in the absence of barriers.
What do experts think would really happen to national LARC use if all the barriers were removed? A team of researchers at University of California, San Francisco—including me—decided to ask.
read the full article »